287 related articles for article (PubMed ID: 33861527)
21. Application of Theranostics in Oncology.
Lymperopoulos G; Lymperopoulos P; Alikari V; Dafogianni C; Zyga S; Margari N
Adv Exp Med Biol; 2017; 989():119-128. PubMed ID: 28971421
[TBL] [Abstract][Full Text] [Related]
22. Emerging theranostics to combat cancer: a perspective on metal-based nanomaterials.
Agnihotri TG; Gomte SS; Jain A
Drug Dev Ind Pharm; 2022 Nov; 48(11):585-601. PubMed ID: 36448770
[TBL] [Abstract][Full Text] [Related]
23. Magnetic nanoparticles-based diagnostics and theranostics.
Cohen Y; Shoushan SY
Curr Opin Biotechnol; 2013 Aug; 24(4):672-81. PubMed ID: 23415743
[TBL] [Abstract][Full Text] [Related]
24. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
Kundu P; Singh D; Singh A; Sahoo SK
Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
[TBL] [Abstract][Full Text] [Related]
25. DNA Nanostructures and DNA-Functionalized Nanoparticles for Cancer Theranostics.
Nicolson F; Ali A; Kircher MF; Pal S
Adv Sci (Weinh); 2020 Dec; 7(23):2001669. PubMed ID: 33304747
[TBL] [Abstract][Full Text] [Related]
26. Porphyrin Nanocage-Embedded Single-Molecular Nanoparticles for Cancer Nanotheranostics.
Yu G; Cen TY; He Z; Wang SP; Wang Z; Ying XW; Li S; Jacobson O; Wang S; Wang L; Lin LS; Tian R; Zhou Z; Ni Q; Li X; Chen X
Angew Chem Int Ed Engl; 2019 Jun; 58(26):8799-8803. PubMed ID: 31034679
[TBL] [Abstract][Full Text] [Related]
27. Recent progress of carbon dots in targeted bioimaging and cancer therapy.
Shen CL; Liu HR; Lou Q; Wang F; Liu KK; Dong L; Shan CX
Theranostics; 2022; 12(6):2860-2893. PubMed ID: 35401835
[TBL] [Abstract][Full Text] [Related]
28. Functional gadolinium-based nanoscale systems for cancer theranostics.
Li H; Zeng Y; Zhang H; Gu Z; Gong Q; Luo K
J Control Release; 2021 Jan; 329():482-512. PubMed ID: 32898594
[TBL] [Abstract][Full Text] [Related]
29. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
[TBL] [Abstract][Full Text] [Related]
30. Current status of Cancer Nanotheranostics: Emerging strategies for cancer management.
Chavda VP; Khadela A; Shah Y; Postwala H; Balar P; Vora L
Nanotheranostics; 2023; 7(4):368-379. PubMed ID: 37151802
[TBL] [Abstract][Full Text] [Related]
31. Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer.
Rajkumar S; Prabaharan M
Curr Top Med Chem; 2017; 17(16):1858-1871. PubMed ID: 27875977
[TBL] [Abstract][Full Text] [Related]
32. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
33. Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics.
Bukhari SZ; Zeth K; Iftikhar M; Rehman M; Usman Munir M; Khan WS; Ihsan A
Curr Res Pharmacol Drug Discov; 2021; 2():100067. PubMed ID: 34909685
[TBL] [Abstract][Full Text] [Related]
34. Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview.
Lungu II; Grumezescu AM; Volceanov A; Andronescu E
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574993
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional Carbon-Based Nanoparticles: Theranostic Applications in Cancer Therapy and Diagnosis.
Hosseini SM; Mohammadnejad J; Najafi-Taher R; Zadeh ZB; Tanhaei M; Ramakrishna S
ACS Appl Bio Mater; 2023 Apr; 6(4):1323-1338. PubMed ID: 36921253
[TBL] [Abstract][Full Text] [Related]
36. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
[TBL] [Abstract][Full Text] [Related]
37. Threatening cancer with nanoparticle aided combination oncotherapy.
Rawal S; Patel MM
J Control Release; 2019 May; 301():76-109. PubMed ID: 30890445
[TBL] [Abstract][Full Text] [Related]
38. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
[TBL] [Abstract][Full Text] [Related]
39. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
[TBL] [Abstract][Full Text] [Related]
40. Choice of Nanoparticles for Theranostics Engineering: Surface Coating to Nanovalves Approach.
Prasad R; Selvaraj K
Nanotheranostics; 2024; 8(1):12-32. PubMed ID: 38164501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
